Tradestie Institutional Equity Comparison Engine

SGHT vs BMRA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SGHT Overall Edge

SGHT Captures Institutional Edge (3โ€“0 Pillars ยท 7โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Sight Sciences, Inc. Common Stock (SGHT) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, SGHT trades at N/M Forward P/E with -20.2% operating margin (+25.2% YoY revenue) versus BMRA at N/M Forward P/E and -125.2% operating margin (-8.3% YoY). In options structure, SGHT sits in BREAKOUT (8th %ile IV; Dealer Gamma Walls on Pro) against BMRA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
SGHT N/M vs BMRA N/M Fwd P/E
Growth & Margin Winner SGHT
Op Margin -20.2% vs -125.2% ยท YoY +25.2% vs -8.3%
Momentum & Technical Winner SGHT
1Y +50.6% vs -46.9% ยท 52W Pos 88% vs 4%
Options & Structure Winner SGHT
BREAKOUT (8th %ile IV) vs UNCLASSIFIED (N/A IV)
SGHT NASDAQ
Sight Sciences, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$10.62
-1.94% 1D
Market Cap $610.8M
1M Return +28.26%
1Y Return +50.64%
Forward P/E N/M
Unified AI Score
35.1 / 100 SELL
Tech 50.0 Fund 32.0 Flow 57.0 Mom 50.0
BMRA NASDAQ
Biomerica Inc
In Vitro & In Vivo Diagnostic Substances
$1.33
-2.32% 1D
Market Cap $6.0M
1M Return -28.19%
1Y Return -46.86%
Forward P/E N/M
Unified AI Score
44.5 / 100 HOLD
Tech 40.0 Fund 47.0 Flow 50.0 Mom 44.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SGHT +50.64% BMRA -46.86% Spread: +97.5 pp (SGHT Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period SGHT Revenue BMRA Revenue SGHT Op. Margin BMRA Op. Margin Margin Edge
FY2019 N/A $10M N/A -46.4% BMRA
FY2020 $30M $10M -116.5% -41.0% BMRA
FY2021 $50M $10M -105.2% -104.2% BMRA
FY2022 $70M $20M -117.7% -24.0% BMRA
FY2023 $80M $10M -70.7% -135.3% SGHT
FY2024 $80M $10M -63.3% -117.6% SGHT
FY2025 $80M $10M -48.0% -96.7% SGHT
FY2026 N/A $0M N/A -119.5% BMRA

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SGHT (7) vs BMRA (1)
Institutional Metric SGHT BMRA Criterion Row Winner
Market Capitalization Scale $610.8M $6.0M Larger Scale SGHT
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +25.2% -8.3% Higher Growth SGHT
Operating Margin (TTM) Profitability -20.2% -125.2% Higher Margin SGHT
Net Profit Margin Profitability -32.1% -115.5% Higher Margin SGHT
Return on Equity (ROE) Capital Efficiency -50.1% -113.8% Higher ROE SGHT
52-Week Range Position Momentum 88% ($3โ€“$12) 4% ($1โ€“$3) Stronger Trend SGHT
Beta / 30D Volatility Risk Regime 1.06ฮฒ ยท 46% Vol 0.67ฮฒ ยท 62% Vol Lower Realized Risk SGHT
Unified Institutional Score Composite Signal 35.1 / 100 (SELL) 44.5 / 100 (HOLD) Higher Composite BMRA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SGHT vs BMRA Buy Guide
SGHT BREAKOUT
33d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 8th %ile
IV Regime Compressed (<25th %ile)
Live SGHT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
BMRA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BMRA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SGHT nor BMRA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.